LeapFinancial | $3,500,000 | (Dec 20, 2024)
TG0 | $5,619,170 | (Dec 20, 2024)
Mindgard | $8,000,000 | (Dec 20, 2024)
Certified by Founder
Lodge
Inspire Biotherapeutics Inc
start up
Canada
- Toronto, Ontario
- 17/03/2023
- Pre-Seed
- Undisclosed Amount
Inspire has developed a lung tropic AAV gene therapy platform that has demonstrated transduction and long-term expression in lung tissue without impact on other tissue types in disease-relevant animal models. We are currently pursing initiation of a Proof-of-Concept clinical trial for a lethal neonatal lung disease with short time to data readout and success of therapy. The platform can then be applied to Cystic Fibrosis and other monogenic lung diseases.
- Industry Biotechnology Research
- Website https://www.inspirebiotx.com/
- LinkedIn https://www.linkedin.com/company/inspire-biotherapeutics-inc/people/
Related People
Sandra DonaldsonFounder
Canada -
Toronto, Ontario
VP & COO OIRM. CEO & COO, Inspire Biotherapeutics. Experienced executive with a demonstrated history of nurturing research networks into thriving ecosystems while working in biotechnology and clinical trial sectors.
ŌURA | $200,000,000 | (Dec 20, 2024)
Buildpeer | $2,500,000 | (Dec 20, 2024)
Embeddable | $6,238,050 | (Dec 20, 2024)
Tenor | $5,400,000 | (Dec 20, 2024)
SOTELIX Endoscopy | $1,700,000 | (Dec 20, 2024)
Double(US) | $3,900,000 | (Dec 20, 2024)
Hauler Hero | $10,000,000 | (Dec 20, 2024)
TripSuite | $5,000,000 | (Dec 20, 2024)
Seekho | $8,000,000 | (Dec 19, 2024)